AROUND 20 MILLION UK ADULTS currently have signs of tooth decay – according to new data – even though it is entirely preventable. More than one-in-three (36%) British adults have had toothache during the pandemic – one of the leading signs of tooth decay. The Oral Health Foundation, a charity working to improve oral health […]
AROUND 20 MILLION UK ADULTS currently have signs of tooth decay – according to new data – even though it is entirely preventable. More than one-in-three (36%) British adults have had toothache during the pandemic – one of the leading signs of tooth decay. The Oral Health Foundation, a charity working to improve oral health […]
Antifibrotic drugs offer hope to thousands of patients who are living with a condition that has a worse outcome than most cancers. · Action for Pulmonary Fibrosis (APF) is delighted to announce their campaign, backed by patients, families and medical experts, to end the inhumane restrictions on life-extending antifibrotic drugs has been successful. · Today […]
Read More… from Victory for thousands of terminally ill patients
Antifibrotic drugs offer hope to thousands of patients who are living with a condition that has a worse outcome than most cancers. · Action for Pulmonary Fibrosis (APF) is delighted to announce their campaign, backed by patients, families and medical experts, to end the inhumane restrictions on life-extending antifibrotic drugs has been successful. · Today […]
Read More… from Victory for thousands of terminally ill patients
Single-dose radiotherapy for breast cancer confirmed to be suitable for most patients: New insights from the TARGIT-A trial Full paper can be accessed at https://doi.org/10.1038/s41416-021-01… and an invited blog post about it is here https://go.nature.com/3ymrplc Previously published Improving breast cancer treatment: Long-term results of the TARGIT-A randomised trial (www.targit.org.uk) of risk-adapted single-dose TARGIT-IORT given during […]
Single-dose radiotherapy for breast cancer confirmed to be suitable for most patients: New insights from the TARGIT-A trial Full paper can be accessed at https://doi.org/10.1038/s41416-021-01… and an invited blog post about it is here https://go.nature.com/3ymrplc Previously published Improving breast cancer treatment: Long-term results of the TARGIT-A randomised trial (www.targit.org.uk) of risk-adapted single-dose TARGIT-IORT given during […]
Single-dose radiotherapy for breast cancer confirmed to be suitable for most patients: Results from further analysis of the large international TARGIT-A trial led from University College London brings more good news for patients diagnosed with breast cancer. Four important questions have been answered by this new analysis. The new paper can be accessed at https://doi.org/10.1038/s41416-021-01440-8 Previously: […]
Single-dose radiotherapy for breast cancer confirmed to be suitable for most patients: Results from further analysis of the large international TARGIT-A trial led from University College London brings more good news for patients diagnosed with breast cancer. Four important questions have been answered by this new analysis. The new paper can be accessed at https://doi.org/10.1038/s41416-021-01440-8 Previously: […]
Inequalities in disability between richest and poorest in the UK more than tripled in past decades, new report finds A new report published today by the International Longevity Centre UK (ILC), drawing on a research project led by Newcastle University, finds that ill health and disability have been on the rise in recent decades, while […]
Read More… from Inequalities in disability report by the ILC
Inequalities in disability between richest and poorest in the UK more than tripled in past decades, new report finds A new report published today by the International Longevity Centre UK (ILC), drawing on a research project led by Newcastle University, finds that ill health and disability have been on the rise in recent decades, while […]
Read More… from Inequalities in disability report by the ILC